| Stage | ULS | % of rev | ARXS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $816M | 100.00% | $564M | 100.00% | ULS ×1.45 |
| Gross profit | $417M | 51.10% | $306M | 54.27% | ARXS +3.2pp |
| Operating income | $150M | 18.38% | $133M | 23.66% | ARXS +5.3pp |
| Pre-tax income | $338M | 41.42% | $120M | 21.23% | ULS +20.2pp |
| Net income | $254M | 31.13% | $84M | 14.84% | ULS +16.3pp |
| Stage | ULS | ARXS | Gap · A − B |
|---|---|---|---|
| Revenue | $816M100.00% | $564M100.00% | ULS ×1.45 |
| Gross profit | 51.10%$417M | 54.27%$306M | ARXS +3.2pp |
| Operating income | 18.38%$150M | 23.66%$133M | ARXS +5.3pp |
| Pre-tax income | 41.42%$338M | 21.23%$120M | ULS +20.2pp |
| Net income |
| 31.13%$254M |
| 14.84%$84M |
| ULS +16.3pp |
No disclosed counterparties: ARXS.
None